Načítá se...
Splice Variants of Androgen Receptor and Prostate Cancer
Over the last ten years, two new-generation hormonal drugs and two chemotherapeutic agents have been approved for the treatment of metastatic castration-resistant prostate cancer. Unfortunately, some patients have primary resistance to them and the others eventually develop secondary resistance. It...
Uloženo v:
| Vydáno v: | Oncol Rev |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
PAGEPress Publications, Pavia, Italy
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4943095/ https://ncbi.nlm.nih.gov/pubmed/27471583 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/oncol.2016.297 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|